2015
DOI: 10.1186/s12910-015-0013-0
|View full text |Cite
|
Sign up to set email alerts
|

The ethics of talking about ‘HIV cure’

Abstract: BackgroundIn 2008, researchers reported that Timothy Brown (the ‘Berlin Patient’), a man with HIV infection and leukemia, received a stem-cell transplant that removed HIV from his body as far as can be detected. In 2013, an infant born with HIV infection received anti-retroviral treatment shortly after birth, but was then lost to the health care system for the next six months. When tested for HIV upon return, the child (the ‘Mississippi Baby’) had no detectable viral load despite cessation of treatment. These … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
39
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(39 citation statements)
references
References 23 publications
0
39
0
Order By: Relevance
“…Individuals on ART have a near normal life expectancy (Wandeler et al, 2016) and in early phase studies aimed at achieving HIV remission or cure, participants are unlikely to have a direct benefit from the intervention while there are also potential risks. These issues have been reviewed elsewhere (Lo et al, 2013; Rennie et al, 2015). In contrast to interventions for malignancy, toxicity of any intervention must be low and the pre-clinical rationale for the study well justified in order to proceed to early phase clinical trials.…”
Section: Potential Challengesmentioning
confidence: 99%
“…Individuals on ART have a near normal life expectancy (Wandeler et al, 2016) and in early phase studies aimed at achieving HIV remission or cure, participants are unlikely to have a direct benefit from the intervention while there are also potential risks. These issues have been reviewed elsewhere (Lo et al, 2013; Rennie et al, 2015). In contrast to interventions for malignancy, toxicity of any intervention must be low and the pre-clinical rationale for the study well justified in order to proceed to early phase clinical trials.…”
Section: Potential Challengesmentioning
confidence: 99%
“…With respect to HIV cure research specifically, it is important to consider how individuals and communities understand basic terminology (e.g., cure, remission, and eradication) [29] and how they weigh and balance competing notions of cure coming from different ‘experts’, including previous or alternative notions of HIV cure that have been discounted by scientists [30]. Additionally, it is important to know how the social construction of cure, including how cure is communicated affects what is and is not studied, as well as what is or is not taken up.…”
Section: Community Policy-maker and Funder Perspectivesmentioning
confidence: 99%
“…Stuart Rennie and colleagues rightly note that ‘HIV cure concepts’ are works in progress 6. In the medical literature, for example, it is more common to find terms like ‘functional cure’ or ‘sterilising HIV cure’.…”
Section: The Power Of the C Wordmentioning
confidence: 99%
“…In the medical literature, for example, it is more common to find terms like ‘functional cure’ or ‘sterilising HIV cure’. The press and the public, on the other hand, are more likely to simply use cure, and are likely (it seems to me) to use it in the way Rennie and colleagues tell us it is found as the first definition in Merriam-Webster Medical Dictionary: ‘recovery from a disease (“his cure was complete”)’ 6. In this regard, cure can also be used as a short hand for permanent disease remission: HIV may still be detectable, but it has no health impact on an individual and requires no further treatment.…”
Section: The Power Of the C Wordmentioning
confidence: 99%
See 1 more Smart Citation